BLU
bluebird bio
Stock
Stock
ISIN: US09609G2093
Ticker: BLUE
US09609G2093
BLUE
Price
Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for bluebird bio?
bluebird bio's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -20.61. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for bluebird bio's stock?
Currently, 1 analysts cover bluebird bio's stock, with a consensus target price of $8.00. Analyst ratings provide insights into the stock's expected performance.
What is bluebird bio's revenue over the trailing twelve months?
Over the trailing twelve months, bluebird bio reported a revenue of $103.95M.
What is the EBITDA for bluebird bio?
bluebird bio's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$149.20M. EBITDA measures the company's overall financial performance.
What is the free cash flow of bluebird bio?
bluebird bio has a free cash flow of -$230.47M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does bluebird bio have, and what sector and industry does it belong to?
bluebird bio employs approximately 248 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
Financials
- EPS (TTM)
- -20.61
- Revenue (TTM)
- $103.95M
- EBITDA (TTM)
- -$149.20M
- Free Cashflow (TTM)
- -$230.47M
Analyst Ratings
The price target is $8.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
- Employees
- 248
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US09609G2093
- Primary Ticker
- BLUE
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet